Cargando…
TNBC-derived Gal3BP/Gal3 complex induces immunosuppression through CD45 receptor
A preliminary study investigating immunotherapy strategies for aggressive triple negative breast cancer (TNBC) revealed an overexpression of genes involved in the release of extracellular vesicles (EVs). Proteins expressed by EVs play a role in reprogramming the tumor microenvironment and impeding e...
Autores principales: | Raiter, Annat, Lipovetsky, Julia, Stenbac, Asaf, Lubin, Ido, Yerushalmi, Rinat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431740/ https://www.ncbi.nlm.nih.gov/pubmed/37593677 http://dx.doi.org/10.1080/2162402X.2023.2246322 |
Ejemplares similares
-
A novel role for an old target: CD45 for breast cancer immunotherapy
por: Raiter, Annat, et al.
Publicado: (2021) -
Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide
por: Alon, Danny, et al.
Publicado: (2021) -
GRP78 expression in peripheral blood mononuclear cells is a new predictive marker for the benefit of taxanes in breast cancer neoadjuvant treatment
por: Raiter, Annat, et al.
Publicado: (2020) -
Chemotherapy Controls Metastasis Through Stimulatory Effects on GRP78 and Its Transcription Factor CREB3L1
por: Raiter, Annat, et al.
Publicado: (2020) -
Pharmacological induction of cell surface GRP78 contributes to apoptosis in triple negative breast cancer cells
por: Raiter, Annat, et al.
Publicado: (2014)